Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02197897
Title Evaluation the Treatment of Tamoxifen of Low/Intermediate Risk Bladder Tumors
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Baylor College of Medicine
Indications

bladder urothelial carcinoma

Therapies

Tamoxifen

Age Groups: adult
Covered Countries USA


No variant requirements are available.